John T. Vetto, M.D., FACS, FASA, is a Professor of Surgery at Oregon Health & Science University. A surgical oncologist specializing in cutaneous malignancies, his research focuses on melanoma prognosis, sentinel lymph node staging, and in-transit metastasis management. His recent work evaluates recurrence risk stratification in stage IIB/C melanoma, predictive factors for in-transit disease, and real-world outcomes of commercial tumor-infiltrating lymphocyte (TIL) therapy with lifileucel. He has contributed multicenter analyses through the Sentinel Lymph Node Working Group and published extensively in the *Journal of Clinical Oncology* and *Annals of Surgical Oncology*.
See moreHonors

Experiences

Education
